These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1389287)

  • 1. Heart valve bioprostheses: antimineralization.
    Schoen FJ; Levy RJ
    Eur J Cardiothorac Surg; 1992; 6 Suppl 1():S91-3; discussion S94. PubMed ID: 1389287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
    Flomenbaum MA; Schoen FJ
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):154-64. PubMed ID: 8419696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention.
    Schoen FJ; Harasaki H; Kim KM; Anderson HC; Levy RJ
    J Biomed Mater Res; 1988 Apr; 22(A1 Suppl):11-36. PubMed ID: 3286652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcification of tissue heart valve substitutes: progress toward understanding and prevention.
    Schoen FJ; Levy RJ
    Ann Thorac Surg; 2005 Mar; 79(3):1072-80. PubMed ID: 15734452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset and progression of experimental bioprosthetic heart valve calcification.
    Schoen FJ; Levy RJ; Nelson AC; Bernhard WF; Nashef A; Hawley M
    Lab Invest; 1985 May; 52(5):523-32. PubMed ID: 3990244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety.
    Schoen FJ; Levy RJ; Hilbert SL; Bianco RW
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1285-8. PubMed ID: 1434707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations.
    Levy RJ; Schoen FJ; Flowers WB; Staelin ST
    J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium.
    Schoen FJ
    J Heart Valve Dis; 1998 Mar; 7(2):174-9. PubMed ID: 9587858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing calcification of cardiac bioprostheses in adolescent sheep.
    Flameng W; Meuris B; Yperman J; De Visscher G; Herijgers P; Verbeken E
    J Thorac Cardiovasc Surg; 2006 Jul; 132(1):89-98. PubMed ID: 16798307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphogenesis of calcification in porcine bioprosthesis: insight from high resolution electron microscopic investigation at molecular and atomic resolution.
    Lee YS
    J Electron Microsc (Tokyo); 1993 Jun; 42(3):156-65. PubMed ID: 8397272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):226-34. PubMed ID: 12701796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic findings in explanted Hancock II porcine bioprostheses.
    Butany J; Yu W; Silver MD; David TE
    J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of bioprosthetic heart valve tissue calcification by charge modification: effects of protamine binding by formaldehyde.
    Golomb G; Ezra V
    J Biomed Mater Res; 1991 Jan; 25(1):85-98. PubMed ID: 1902234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ways to prevent the calcification of heart valve bioprostheses].
    Barbarash LS; Zhuravleva IIu; Medvedeva VM; Shaposhnikov AN
    Biull Eksp Biol Med; 1988 Dec; 106(12):732-4. PubMed ID: 3207883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations.
    Levy RJ; Schoen FJ; Lund SA; Smith MS
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):551-7. PubMed ID: 3116348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.
    De La Fuente AB; Wright GA; Olin JM; Duhay FG; Kapelak B; Bochenek M; Bartus K; Sadowski J
    J Heart Valve Dis; 2015 Jan; 24(1):101-9. PubMed ID: 26182627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism.
    Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ
    J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mechanical stress in calcification of aortic bioprosthetic valves.
    Thubrikar MJ; Deck JD; Aouad J; Nolan SP
    J Thorac Cardiovasc Surg; 1983 Jul; 86(1):115-25. PubMed ID: 6865456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue.
    Meuris B; Ozaki S; Herijgers P; Verbeken E; Flameng W
    Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):99-105. PubMed ID: 11805957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of the Pericarbon bovine pericardial xenograft implanted in humans.
    Valente M; Ius P; Bortolotti U; Talenti E; Bottio T; Thiene G
    J Heart Valve Dis; 1998 Mar; 7(2):180-9. PubMed ID: 9587859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.